Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels.
Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels.
复制标题
DOI:
10.1038/s41372-021-00995-x
复制
发表时间:
2021-04
期刊:
影响因子:
--
通讯作者:
Slaughter JL
中科院分区:
文献类型:
--
作者:
Abdi HH;Backes CH;Ball MK;Talavera-Barber MM;Klebanoff MA;Jadcherla SR;Mohamed TH;Slaughter JL
To identify the relationship between prophylactic indomethacin (PI) administration and 1) mortality and bronchopulmonary dysplasia (BPD) at 36-weeks postmenstrual age (PMA) (primary outcome), and 2) to evaluate for PI-associated acute kidney injury. Retrospective cohort investigation of 22–28 weeks gestation infants (N=1,167) who were admitted to Nationwide Children’s Hospital on postnatal days 0–1 between May 2009-September 2017 and survived ≥24-hours postnatal. The associations of PI treatment with mortality or BPD, and other secondary outcomes, was evaluated via multivariable robust-error-variance Poisson regression. The adjusted risks of death or BPD (1.02, 95% CI: 0.83, 1.25), BPD (0.97, 95% CI: 0.77, 1.21), and death 1.33 (95% CI: 0.84, 2.10) by 36-weeks PMA were unchanged following PI treatment after multivariable adjustment. No changes in mean creatinine levels were detected in exposed versus unexposed infants to suggest PI-induced AKI. Prophylactic indomethacin treatment was unrelated to mortality or BPD outcomes.
登录
查看更多内容
影响因子:
5.1
作者:
Couser, RJ;Ferrara, TB;Payne, NR
通讯作者:
Payne, NR
影响因子:
26.1
作者:
Slaughter JL;Reagan PB;Newman TB;Klebanoff MA
通讯作者:
Klebanoff MA
影响因子:
5.1
作者:
Jensen, Erik A.;Dysart, Kevin C.;Schmidt, Barbara
通讯作者:
Schmidt, Barbara
影响因子:
8
作者:
Selewski, David T.;Charlton, Jennifer R.;Kent, Alison L.
通讯作者:
Kent, Alison L.
影响因子:
3
作者:
Nada, Arwa;Bonachea, Elizabeth M.;Askenazi, David J.
通讯作者:
Askenazi, David J.